Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elias Castanas

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
ACS Omega|November 15, 2021
New Antagonists of the Membrane Androgen Receptor OXER1 from the ZINC Natural Product DatabaseAthanasios A Panagiotopoulos, Konstantina Kalyvianaki, George Notas, et al.
Leukemia Research|November 16, 2004
Cancer chemotherapy reduces plasma total antioxidant capacity in children with malignanciesMaria Papageorgiou, Eftichia Stiakaki, Helen Dimitriou, et al.
Experimental Cell Research|March 17, 2004
The opioid agonist ethylketocyclazocine reverts the rapid, non-genomic effects of membrane testosterone receptors in the human prostate LNCaP cell lineMarilena Kampa, Evangelia A Papakonstanti, Vassilia-Ismini Alexaki, et al.
Cells|February 25, 2023
Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast CancerMarilena Kampa, Rosamaria Lappano, Fedora Grande, et al.
Molecular and Cellular Endocrinology|October 11, 2021
OXER1 mediates testosterone-induced calcium responses in prostate cancer cellsAthanasios A Panagiotopoulos, Konstantina Kalyvianaki, Bourcin Serifoglou, et al.
Plos One|December 31, 2013
BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysisVassiliki Pelekanou, George Notas, Marilena Kampa, et al.
Experimental Cell Research|July 25, 2003
Distinct signaling pathways regulate differential opioid effects on actin cytoskeleton in malignant MCF7 and nonmalignant MCF12A human breast epithelial cellsGalatea Kallergi, Anna Tsapara, Marilena Kampa, et al.
Cell Calcium|October 21, 2005
ICPBC and C12-ICPBC: two new red emitting, fluorescent Ca2+ indicators excited with visible lightEmmanuel Roussakis, Fotini Liepouri, Artemissia-Phoebe Nifli, et al.
Digestive Diseases and Sciences|October 16, 2004
Decreased total and corrected antioxidant capacity in patients with inflammatory bowel diseaseIoannis E Koutroubakis, Niki Malliaraki, Philippos D Dimoulios, et al.
Journal of Thyroid Research|December 17, 2011
First- and Second-Trimester Reference Intervals for Thyroid Hormones during Pregnancy in "Rhea" Mother-Child Cohort, Crete, GreecePolyxeni Karakosta, Leda Chatzi, Emmanouil Bagkeris, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
ACS Omega|November 15, 2021
New Antagonists of the Membrane Androgen Receptor OXER1 from the ZINC Natural Product DatabaseAthanasios A Panagiotopoulos, Konstantina Kalyvianaki, George Notas, et al.
Leukemia Research|November 16, 2004
Cancer chemotherapy reduces plasma total antioxidant capacity in children with malignanciesMaria Papageorgiou, Eftichia Stiakaki, Helen Dimitriou, et al.
Experimental Cell Research|March 17, 2004
The opioid agonist ethylketocyclazocine reverts the rapid, non-genomic effects of membrane testosterone receptors in the human prostate LNCaP cell lineMarilena Kampa, Evangelia A Papakonstanti, Vassilia-Ismini Alexaki, et al.
Cells|February 25, 2023
Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast CancerMarilena Kampa, Rosamaria Lappano, Fedora Grande, et al.
Molecular and Cellular Endocrinology|October 11, 2021
OXER1 mediates testosterone-induced calcium responses in prostate cancer cellsAthanasios A Panagiotopoulos, Konstantina Kalyvianaki, Bourcin Serifoglou, et al.
Plos One|December 31, 2013
BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysisVassiliki Pelekanou, George Notas, Marilena Kampa, et al.
Experimental Cell Research|July 25, 2003
Distinct signaling pathways regulate differential opioid effects on actin cytoskeleton in malignant MCF7 and nonmalignant MCF12A human breast epithelial cellsGalatea Kallergi, Anna Tsapara, Marilena Kampa, et al.
Cell Calcium|October 21, 2005
ICPBC and C12-ICPBC: two new red emitting, fluorescent Ca2+ indicators excited with visible lightEmmanuel Roussakis, Fotini Liepouri, Artemissia-Phoebe Nifli, et al.
Digestive Diseases and Sciences|October 16, 2004
Decreased total and corrected antioxidant capacity in patients with inflammatory bowel diseaseIoannis E Koutroubakis, Niki Malliaraki, Philippos D Dimoulios, et al.
Journal of Thyroid Research|December 17, 2011
First- and Second-Trimester Reference Intervals for Thyroid Hormones during Pregnancy in "Rhea" Mother-Child Cohort, Crete, GreecePolyxeni Karakosta, Leda Chatzi, Emmanouil Bagkeris, et al.
Pageof 13